Manufacturer's drug interaction and postmarketing adverse event data: what are appropriate uses?Published in:2001By:Kraft, W.K.;Waldman, S.A.Publication type:journal article
Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management.Published in:2001By:Behrend, M.Publication type:journal article
Risks and Benefits of Soy Phytoestrogens in Cardiovascular Diseases, Cancer, Climacteric Symptoms and Osteoporosis.Published in:Drug Safety, 2001, v. 24, n. 9, p. 665, doi. 10.2165/00002018-200124090-00003By:Sirtori, C.R.Publication type:Article
Antiretroviral therapy in pregnancy: a focus on safety.Published in:2001By:Taylor, G.P.;Low-Beer, N.Publication type:journal article
Safety profile of tolterodine as used in general practice in England: results of prescription-event monitoring.Published in:2001By:Layton, D.;Pearce, G.L.;Shakir, S.A.W.;Shakir, S APublication type:journal article